ARGX Q2 2022 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena

ARGXargenx SE

$46B

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$111M-73.5% YoY

Gross Profit

-$169M-151.4% margin

Operating Income

-$379M-340.5% margin

Net Income

-$416M-373.7% margin

EPS (Diluted)

$-7.78

Cash Flow

Operating Cash Flow

-$472M

Free Cash Flow

-$472M

Stock-Based Comp.

$77M

Balance Sheet

Total Assets

$3.2B

Total Liabilities

$279M

Stockholders' Equity

$3.0B

Cash & Equivalents

$1.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$111M	$420M	-73.5%
Gross Profit	-$169M	$189M	-189.0%
Operating Income	-$379M	$80M	-572.8%
Net Income	-$416M	$53M	-881.2%

Geographic Segments

United States

$94M98%

Japan

$2M2%

Other

$133,0000%